Pharma Stocks: Dr Reddy s Laboratories, Sun Pharma and Aurobindo Pharma are recalling products in the US market due to manufacturing issues, as per the latest Enforcement Report of the US Food and Drug Administration (USFDA).
Adani Enterprises received two show cause notices (SCNs) from the Sebi over Hindenburg report in Q4FY24, alleging non-compliance of its provisions of the listing agreements and disclosure requirements (LODR regulations), the company stated in its filing to the exchanges, will keep stock in focus.